The NOAHE Health Economics and Technology Assessment Rounds are presented by the Institute of Health Economics, the University of Calgary Health Economics Group and HTA Unit, and the University of Alberta Health Economics Unit. Their aim is to advance health economics research and support evidence-based health policy, to improve the health outcomes of Canadians.
Round Objectives
- To present research on topics of relevance to Health Economists, trainees, and policy makers across Alberta.
- To bring experts in Health Economics to Alberta to present on cutting edge research.
- To encourage collaboration and discourse between Alberta health economists, and with policy makers.
Please note that the views expressed in this series and other deliverables associated with NOAHE are not necessarily representative of any particular organization involved.
2020 - 2021 Dates
NOTE: All NOAHE Rounds IV Sessions will be online-only.
Upcoming Session Information
*Individual session information will be updated as available*
February 17, 2021 - Session 6
Topic: Approaches and Challenges of Valuing of Next Generation Sequencing (NGS) in Precision Health using Preferences
Presenter Name: Deborah A Marshall, Professor and Arthur J.E. Child Chair, University of Calgary
Abstract: Even in the era of precision health, the implementation of next generation sequencing (NGS) into clinical practice has been variable. There have been few economic studies that have examined patient preferences that reflect both health and nonhealthy outcomes associated with NGS. The complexity of information, uncertainty, multiple risks and potential downstream consequences from NGS testing makes it challenging to fully assess its value. Preference methods continue to grow in their relevance and application in health as a powerful tool for including the patient voice in clinical decision making and health policy to increase patient-centeredness. This presentation will focus on preferences studies and examples of how they can be used in a variety of applications ranging from identifying patient-relevant outcomes, valuing patient-reported outcomes, prioritizing important measures of quality of care, and facilitating deliberations in both the clinical and health policy context, particularly with respect to precision medicine and next generation sequencing.
March 17, 2021 - Session 7
Topic: TBD
Presenter Name: TBD
Abstract:TBD
April 21, 2021 - Session 8
Topic: TBD
Presenter Name: TBD
Abstract:TBD
May 19, 2021 - Session 9
Topic: TBD
Presenter Name: TBD
Abstract:TBD
